Fairmount Partners Research
Advisory Approach
Fairmount Partners is an independent investment banking firm founded in 2003 that focuses exclusively on serving middle-market and emerging growth companies. The firm's strategic thesis centers on the belief that founder-owned and PE-backed companies require specialized M&A advisory expertise distinct from large bulge-bracket banks. Fairmount positions itself as a partner that combines institutional-level transaction execution capabilities with entrepreneurial agility, allowing them to serve clients with enterprise values typically between $10M and $500M. The firm's approach emphasizes comprehensive buyer outreach, process discipline, and deep industry knowledge across four primary sectors: healthcare/pharma, technology/SaaS, consulting & technology services, and industrial & consumer products.
Sector Focus & Industry Expertise
Fairmount Partners maintains sophisticated practices across multiple verticals, each with demonstrated deal track records. The healthcare practice is particularly well-developed, with the founding partner Cornelius P. "Neal" McCarthy leveraging 25+ years of healthcare investment banking experience. This practice covers pharmaceutical outsourced services (contract research organizations, contract manufacturing organizations), specialty pharmaceuticals, pharmaceutical services, medical devices, and life sciences platforms. Notable healthcare transactions include the Clariness-SubjectWell merger (2026), a transformational platform combination creating one of the largest global patient recruitment platforms with presence in 60+ countries, and Nixon Medical's acquisition of A Linen Connection's medical business division. The pharma services team alone has completed over 195 transactions across 24 countries.
The consulting & technology services practice, led by Managing Director Andy Brown, specializes in IT consulting, staffing and professional HR services, outsourced accounting and Office of the CFO services, and outsourced healthcare and pharmaceutical services. Mr. Brown has been instrumental in over 65+ transactions representing more than $4 billion in aggregate transaction value. Representative deals include Your Part-Time Controller's majority recapitalization with Pamlico Capital, Aditi Consulting's acquisition of Resolvit, and LaSalle Network's recapitalization with Infinedi Partners.
The technology/SaaS practice focuses on emerging growth software companies, SaaS platforms, and industrial software/IoT companies. Fairmount publishes regular SaaS industry updates and tracks 100+ public SaaS companies, demonstrating deep market knowledge. The firm also advises on enterprise software acquisitions and platform consolidation transactions.
The industrial & consumer practice serves manufacturers, material handling businesses, and industrial services firms. Recent transactions include Ballymore Safety Products' acquisition of Equipto (a mobile racking and storage solutions manufacturer founded in 1907 with ~100 employees), which was Ballymore's third acquisition since One Equity's 2024 platform investment. Fairmount also advised Kistler O'Brien Fire Protection on its 2023 sale to a strategic acquirer, helping a 90+ year family business transition to new ownership while preserving its culture and customer relationships.
Deal Track Record & Transaction Volume
Since founding in 2003, Fairmount has closed over 320 domestic and international transactions representing over $18 billion in aggregate transaction value. The firm operates across North and South America, Europe, Asia, Australia, and the Middle East, with particular strength in cross-border transactions (having executed deals with parties in Argentina, Canada, England, Finland, Germany, India, Ireland, Japan, Poland, Switzerland, and Uruguay). Recent transaction activity (2023-2026) demonstrates sustained deal flow and market presence: Kistler O'Brien Fire Protection strategic sale (Oct 2023), Nixon Medical acquisition (Jan 2024), Techniserv sale to Masco Group (Jun 2025), Ballymore/Equipto acquisition (Sep 2025), Pressure Chemical Co. sale (May 2025), Atlantic Research Group merger (Jul 2025), InSource ServiceNow business unit sale to CoreX (Jan 2026), and Clariness-SubjectWell merger (Jan 2026).
Service Offerings & Transaction Types
Fairmount provides a comprehensive range of investment banking services: sell-side M&A advisory (the primary focus), buy-side M&A advisory, minority and majority equity recapitalizations, growth equity placement, debt financing for acquisitions and buyouts, management buyout facilitation, and financial advisory services. The firm structures transactions across multiple deal types: traditional sell-side processes, buy-side advisory for PE firms and strategics, recapitalizations and growth equity, and management-led transactions.
Process & Fee Structure
Fairmount's engagement model follows institutional M&A banking standards. Sell-side processes typically involve a comprehensive buyer search with 200-300+ targeted buyer outreach. The firm provides strategic advisory on transaction structure, valuation benchmarking, buyer targeting and qualification, management presentation preparation, data room organization, and ongoing deal management through close. Engagement timelines typically range from 6-12 months depending on transaction complexity and market conditions. While specific retainer and success fee structures are not published on the firm's website, industry standards for independent middle-market banks in this segment typically involve: modified Lehman formula success fees (approximately 3-5% on total enterprise value), monthly retainers of $10,000-$25,000 (credited against success fees), and minimum engagement sizes in the $10M-$15M TEV range to ensure deal teams are properly resourced.
Buyer Network & Strategic Relationships
Fairmount has established relationships with a broad network of strategic acquirers and financial sponsors. From recent deal flow, identified PE relationships include One Equity Partners (who invested in Ballymore before it acquired Equipto), Infinedi Partners (in recapitalizations), Pamlico Capital, WestView Capital, and FFL Partners. Strategic buyer relationships span industrial manufacturing firms, large staffing and professional services consolidators (including publicly traded companies like Randstad NV, ASGN Incorporated, Kelly Services), telecommunications and technology infrastructure companies, and healthcare platform investors. The firm has also worked with major law firms (Baker Hostetler, Klehr Harrison Harvey Branzburg, Cozen O'Connor) and transaction service providers (Gattuso Group, Normandy Advisors) that indicate a professional, institutional transaction management approach.
Competitive Positioning
Fairmount differentiates through: (1) specialized sector expertise with dedicated practices led by senior professionals with 20+ years of industry experience, (2) institutional transaction discipline and process orientation while maintaining entrepreneurial agility, (3) geographic diversity and cross-border transaction experience, (4) FINRA broker-dealer registration providing regulatory credibility, (5) track record of successful transition transactions that balance founder/family interests with operational and financial performance, and (6) relationships across both strategic and financial buyers rather than relying solely on one buyer category.
Firm Structure & Team
Fairmount is led by four Managing Directors: Neal McCarthy (founding partner, healthcare/pharma focus), Andy Brown (consulting & technology services), Charles Robins, Jonathan Smith, and Dick Thatcher. The firm maintains a lean team structure with directors, vice presidents, associates, and analysts supporting deal execution. Key team members include: Roy Delizia and R.C. Wainwright (Directors), Hannah Forstner and Mihir Patel (Vice Presidents), with specialized expertise in healthcare, industrial, technology, and professional services sectors. The team's composition suggests origination strength from senior partners and execution support from mid-level bankers and analysts.
Not a Fit If
Fairmount likely declines: transactions below $10M TEV (insufficient deal size for team allocation), pure asset sales without going-concern value, businesses with significant regulatory or litigation issues, companies requiring only financial advisory without transaction execution, and situations where the founder/ownership seeks a limited buyer process.
Geographic Coverage & Headquarters
Headquartered in Radnor, Pennsylvania (Western Philadelphia suburbs), Fairmount operates primarily across North America with significant international transaction experience. The firm's Pennsylvania base positions it well for industrial manufacturing and healthcare services transactions in the Northeast and Midwest corridors, though recent deal activity demonstrates capability across all US regions and international markets.
Regulatory Status
Fairmount Partners is a registered Broker-Dealer with FINRA (CRD# 146668, SEC# 8-67839), and a member of SIPC, providing regulatory oversight and capital-raising capabilities. This distinguishes the firm from advisory-only shops and allows direct engagement in equity placements and capital formation services.